IMMUNE GLOBULIN NOS for Off label use: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where IMMUNE GLOBULIN NOS was used for Off label use.
Most Reported Side Effects for IMMUNE GLOBULIN NOS
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 963 | 42.8% | 228 | 533 |
| Off label use | 675 | 30.0% | 113 | 334 |
| Drug ineffective for unapproved indication | 266 | 11.8% | 69 | 143 |
| Condition aggravated | 207 | 9.2% | 31 | 138 |
| Product use in unapproved indication | 143 | 6.4% | 31 | 52 |
| Therapy non-responder | 130 | 5.8% | 14 | 82 |
| Treatment failure | 121 | 5.4% | 12 | 36 |
| Septic shock | 95 | 4.2% | 31 | 86 |
| Diarrhoea | 92 | 4.1% | 9 | 74 |
| Maternal exposure during pregnancy | 83 | 3.7% | 1 | 40 |
| Vomiting | 83 | 3.7% | 6 | 67 |
| Nausea | 81 | 3.6% | 4 | 54 |
| Drug intolerance | 77 | 3.4% | 1 | 67 |
| Disease progression | 67 | 3.0% | 14 | 22 |
| Intentional product use issue | 67 | 3.0% | 14 | 37 |
Other Indications for IMMUNE GLOBULIN NOS
Product used for unknown indication (292)
Immune thrombocytopenia (100)
Haemophagocytic lymphohistiocytosis (98)
Immunosuppressant drug therapy (98)
Dermatomyositis (92)
Covid-19 (83)
Myasthenia gravis (63)
Encephalitis autoimmune (52)
Interstitial lung disease (48)
Juvenile idiopathic arthritis (47)
Other Drugs Used for Off label use
LENALIDOMIDE (5,767)
ECULIZUMAB (3,550)
CERTOLIZUMAB PEGOL (2,256)
ABOBOTULINUMTOXINA (2,170)
LEVETIRACETAM (2,161)
APREMILAST (1,995)
PROPRANOLOL (1,576)
CETIRIZINE (1,416)
HUMAN IMMUNOGLOBULIN G (1,129)
THALIDOMIDE (1,033)